Haploinsufficiency in PTPN2 leads to early-onset systemic autoimmunity from Evans syndrome to lupus
Journal of Experimental Medicine · 02.09.2024 · 221 (9)
DOI: 10.1084/jem.20232337 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Medicine, online erschienen am 19.07.2024. Verfasst von Marie Jeanpierre und 23 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, Imagine Institute, Université Paris Cité, INSERM UMR 1163 , Paris, France, IHU-Imagine…. Hauptthemen laut MEDLINE: Haploinsufficiency, Protein Tyrosine Phosphatase, Non-Receptor Type 2, Anemia, Hemolytic, Autoimmune, Lupus Erythematosus, Systemic. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0). Gefördert von: Institut National de la Santé et de la Recherche Médicale, Agence Nationale de la Recherche, Centre de Référence Déficits Immunitaires Héréditaires.
Abstract (Originalsprache)
An exome sequencing strategy employed to identify pathogenic variants in patients with pediatric-onset systemic lupus or Evans syndrome resulted in the discovery of six novel monoallelic mutations in PTPN2. PTPN2 is a phosphatase that acts as an essential negative regulator of the JAK/STAT pathways. All mutations led to a loss of PTPN2 regulatory function as evidenced by in vitro assays and by hyperproliferation of patients’ T cells. Furthermore, patients exhibited high serum levels of inflammatory cytokines, mimicking the profile observed in individuals with gain-of-function mutations in STAT factors. Flow cytometry analysis of patients’ blood cells revealed typical alterations associated with autoimmunity and all patients presented with autoantibodies. These findings further supported the notion that a loss of function in negative regulators of cytokine pathways can lead to a broad spectrum of autoimmune manifestations and that PTPN2 along with SOCS1 haploinsufficiency constitute a new group of monogenic autoimmune diseases that can benefit from targeted therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, Imagine Institute, Université Paris Cité, INSERM UMR 1163 , Paris, France, IHU-Imagine, Université de Paris, Paris, France.
- Centre International de Recherche en Infectiologie, Inserm, U1111, CNRS, UMR5308, École Normale Supérieure de Lyon , Lyon, France.
- Department of Medical Genetics, Hospices Civils de Lyon, Bron, France.
- Université Paris Cité, CNRS, Unité de Biologie Fonctionnelle et Adaptative , Paris, France.
- Université Paris Cité, CNRS, Epigenetics and Cell Fate , Paris, France.
- National Referee Centre for Pediatric-Onset Rheumatism and Autoimmune Diseases, Hospices Civils de Lyon, Pediatric Nephrology, Rheumatology, Dermatology Unit, Mother and Children University Hospital ; Lyon, France.
ORCID-Profile: Marie Jeanpierre, Jade Cognard, Maud Tusseau, Quentin Riller, Linh-Chi Bui, Jérémy Berthelet, Audrey Laurent, Etienne Crickx, Marianna Parlato, Marie-Claude Stolzenberg, Felipe Suarez, Guy Leverger, Nathalie Aladjidi, Sophie Collardeau-Frachon, Christine Pietrement, Marion Malphettes, Antoine Froissart, Christine Bole-Feysot, Nicolas Cagnard, Fernando Rodrigues Lima, Thierry Walzer, Frédéric Rieux-Laucat, Alexandre Belot, Anne-Laure Mathieu
Förderung
- Institut National de la Santé et de la Recherche Médicale
- Agence Nationale de la Recherche
- Centre de Référence Déficits Immunitaires Héréditaires
- Fondation ARC pour la recherche sur le Cancer
- Fondation pour la recherche Médicale
- Horizon Europe
- Centre de référence des rhumatismes inflammatoires, des interféronopathies et des maladies autoimmunes
- Centre National de la Recherche Scientifique
Zitieren
APA
Jeanpierre, M., Cognard, J., Tusseau, M., Riller, Q., Bui, L. C., Berthelet, J., Laurent, A., Crickx, E., Parlato, M., Stolzenberg, M. C., Suarez, F., Leverger, G., Aladjidi, N., Collardeau-Frachon, S., Pietrement, C., Malphettes, M., Froissart, A., Bole-Feysot, C., Cagnard, N., …, & Mathieu, A. L. (2024). Haploinsufficiency in PTPN2 leads to early-onset systemic autoimmunity from Evans syndrome to lupus. Journal of Experimental Medicine, 221(9). https://doi.org/10.1084/jem.20232337
Vancouver
Jeanpierre M, Cognard J, Tusseau M, Riller Q, Bui LC, Berthelet J, et al. Haploinsufficiency in PTPN2 leads to early-onset systemic autoimmunity from Evans syndrome to lupus. Journal of Experimental Medicine. 2024;221(9). doi:10.1084/jem.20232337
BibTeX
@article{Jeanpierre2024,
author = {Jeanpierre, Marie and Cognard, Jade and Tusseau, Maud and Riller, Quentin and Bui, Linh-Chi and Berthelet, Jérémy and Laurent, Audrey and Crickx, Etienne and Parlato, Marianna and Stolzenberg, Marie-Claude and Suarez, Felipe and Leverger, Guy and Aladjidi, Nathalie and Collardeau-Frachon, Sophie and Pietrement, Christine and Malphettes, Marion and Froissart, Antoine and Bole-Feysot, Christine and Cagnard, Nicolas and Rodrigues Lima, Fernando and Walzer, Thierry and Rieux-Laucat, Frédéric and Belot, Alexandre and Mathieu, Anne-Laure},
title = {Haploinsufficiency in PTPN2 leads to early-onset systemic autoimmunity from Evans syndrome to lupus},
journal = {Journal of Experimental Medicine},
year = {2024},
volume = {221},
number = {9},
doi = {10.1084/jem.20232337}
}
EUVIMED